Outlier analysis defines zinc finger gene family DNA methylation in tumors and saliva of head and neck cancer patients

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Gaykalova, Daria A ^a   Vatapalli, Rajita ^a,b   Wei, Yingying ^a,c   Tsai, Hua Ling ^a   Wang, Hao ^a   Zhang, Chi ^a,d   Hennessey, Patrick T ^a   Guo, Theresa ^a   Tan, Marietta ^a   Li, Ryan ^a   Ahn, Julie ^a   Khan, Zubair ^a   Westra, William H ^a   Bishop, Justin A ^a   Zaboli, David ^a   Koch, Wayne M ^a   Khan, Tanbir ^a   Ochs, Michael F ^a,e   Califano, Joseph A ^a,f,g  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF VIRGINIA   (United States)

^e The College of New Jersey   (United States)

^f GREATER BALTIMORE MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER; ZINC FINGER PROTEIN; APOPTOSIS REGULATORY PROTEIN; DNA BINDING PROTEIN; REPRESSOR PROTEIN; ZINC FINGER PROTEIN 160, HUMAN; ZNF420 PROTEIN, HUMAN;

ARTICLE; CANCER DIAGNOSIS; COHORT ANALYSIS; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENOME ANALYSIS; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; MULTIGENE FAMILY; SALIVA ANALYSIS; STATISTICAL ANALYSIS; ZINC FINGER GENE; ZNF14 GENE; ZNF160 GENE; ZNF420 GENE; GENE EXPRESSION REGULATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HEAD AND NECK TUMOR; METABOLISM; PAPILLOMAVIRIDAE; SALIVA; SENSITIVITY AND SPECIFICITY; VIROLOGY;

APOPTOSIS REGULATORY PROTEINS; BIOMARKERS, TUMOR; DNA METHYLATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HEAD AND NECK NEOPLASMS; PAPILLOMAVIRIDAE; REPRESSOR PROTEINS; SALIVA; SENSITIVITY AND SPECIFICITY; ZINC FINGERS;

EID: 84952683832     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142148     Document Type: Article

References (50)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015. doi:10.3322/caac.21262 PMID: 25651787.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5-29. doi:10. 3322/caac.21254 PMID: 25559415.
3. Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. The lancet oncology. 2006;7(1):77-82. doi:10.1016/S1470-2045 (05) 70540-4 PMID: 16389187.
4. Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83(4):489-501. Epub 2008/04/03. doi:10.4065/83.4.489 PMID: 18380996.
5. Poage GM, Houseman EA, Christensen BC, Butler RA, Avissar-Whiting M, McClean MD, et al. Global hypomethylation identifies Loci targeted for hypermethylation in head and neck cancer. Clin Cancer Res. 2011;17(11):3579-89. doi:10.1158/1078-0432. CCR-11-0044 PMID: 21505061; PubMed Central PMCID: PMC3107873.
6. Smith IM, Mydlarz WK, Mithani SK, Califano JA. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int J Cancer. 2007;121(8):1724-8. doi:10.1002/ijc.22889 PMID: 17582607.
7. Carvalho AL, Henrique R, Jeronimo C, Nayak CS, Reddy AN, Hoque MO, et al. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Clin Cancer Res. 2011;17(14):4782-9. Epub 2011/06/02. doi:10.1158/1078-0432. CCR-11-0324 PMID: 21628494; PubMed Central PMCID: PMC3215270.
8. Carvalho AL, Jeronimo C, Kim MM, Henrique R, Zhang Z, Hoque MO, et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res. 2008;14(1):97-107. Epub 2008/01/04. doi:10.1158/1078-0432. CCR-07-0722 PMID: 18172258.
9. Pattani KM, Zhang Z, Demokan S, Glazer C, Loyo M, Goodman S, et al. Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res (Phila). 2010;3(9):1093-103. Epub 2010/08/28. doi:10. 1158/1940-6207. CAPR-10-0115 PMID: 20798208; PubMed Central PMCID: PMC2945229.
10. Guerrero-Preston R, Soudry E, Acero J, Orera M, Moreno-Lopez L, Macia-Colon G, et al. NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva. Cancer Prev Res (Phila). 2011;4(7):1061-72. Epub 2011/05/12. doi:10.1158/1940-6207. CAPR-11-0006 PMID: 21558411; PubMed Central PMCID: PMC3131432.
11. Viet CT, Schmidt BL. Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3603-11. doi:10.1158/1055-9965. EPI-08-0507 PMID: 19064577.
12. Worsham MJ, Chen KM, Ghanem T, Stephen JK, Divine G. Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC. Otolaryngol Head Neck Surg. 2013;149(3):409-16. doi:10. 1177/0194599813490895 PMID: 23736812; PubMed Central PMCID: PMC3935612.
13. Lleras RA, Adrien LR, Smith RV, Brown B, Jivraj N, Keller C, et al. Hypermethylation of a cluster of Kruppel-type zinc finger protein genes on chromosome 19q13 in oropharyngeal squamous cell carcinoma. Am J Pathol. 2011;178(5):1965-74. Epub 2011/04/26. doi:10.1016/j.ajpath.2011.01.049 PMID: 21514414; PubMed Central PMCID: PMC3081156.
14. Lleras RA, Smith RV, Adrien LR, Schlecht NF, Burk RD, Harris TM, et al. Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma. Clin Cancer Res. 2013;19(19):5444-55. doi:10.1158/1078-0432. CCR-12-3280 PMID: 23894057; PubMed Central PMCID: PMC3892374.
15. Demokan S, Chang X, Chuang A, Mydlarz WK, Kaur J, Huang P, et al. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses. Int J Cancer. 2010;127(10):2351-9. Epub 2010/02/18. doi:10.1002/ijc.25248 PMID: 20162572; PubMed Central PMCID: PMC2946472.
16. Arantes LM, de Carvalho AC, Melendez ME, Carvalho AL, Goloni-Bertollo EM. Methylation as a biomarker for head and neck cancer. Oral Oncol. 2014;50(6):587-92. doi:10.1016/j.oraloncology.2014. 02.015 PMID: 24656975.
17. Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, et al. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer. 2006;94(4):561-8. Epub 2006/02/02. doi:10.1038/sj.bjc.6602972 PMID: 16449996; PubMed Central PMCID: PMC2361183.
18. Yang J, Ji WY, Qu YR, He LX, Zhao XD, Jin MZ. [DNA methylation and histone modification relate to RASSF1A gene deletion in laryngeal carcinoma tissues]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011;46(4):308-12. Epub 2011/06/01. PMID: 21624251.
19. He Q, Wei J, Zhang J, Jiang H, Wang S, Zhou X, et al. Aberrant methylation of secreted protein, acidic and rich in cysteine in human laryngeal and hypopharyngeal carcinoma. Oncol Lett. 2011;2(4):725-9. Epub 2012/08/01. doi:10.3892/ol. 2011.297 PMID: 22848256; PubMed Central PMCID: PMC3406334.
20. Sharma R, Panda NK, Khullar M. Hypermethylation of carcinogen metabolism genes, CYP1A1, CYP2A13 and GSTM1 genes in head and neck cancer. Oral Dis. 2010;16(7):668-73. Epub 2010/09/18. doi:10.1111/j.1601-0825.2010.01676.x PMID: 20846153.
21. Calmon MF, Rodrigues RV, Kaneto CM, Moura RP, Silva SD, Mota LD, et al. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia. 2009;11(12):1329-39. Epub 2009/12/19. PMID: 20019841; PubMed Central PMCID: PMC2794514.
22. Hartmann S, Szaumkessel M, Salaverria I, Simon R, Sauter G, Kiwerska K, et al. Loss of protein expression and recurrent DNA hypermethylation of the GNG7 gene in squamous cell carcinoma of the head and neck. J Appl Genet. 2012;53(2):167-74. Epub 2011/12/21. doi:10.1007/s13353-011-0079-4 PMID: 22183866; PubMed Central PMCID: PMC3334494.
23. Belbin TJ, Schlecht NF, Smith RV, Adrien LR, Kawachi N, Brandwein-Gensler M, et al. Site-specific molecular signatures predict aggressive disease in HNSCC. Head Neck Pathol. 2008;2(4):243-56. Epub 2008/12/01. doi:10.1007/s12105-008-0071-4 PMID: 20614290; PubMed Central PMCID: PMC2807580.
24. Sun W, Zaboli D, Wang H, Liu Y, Arnaoutakis D, Khan T, et al. Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer. Clin Cancer Res. 2012;18(4):1082-91. Epub 2012/01/10. doi:10.1158/1078-0432. CCR-11-2392 PMID: 22228635; PubMed Central PMCID: PMC3288549.
25. Schussel J, Zhou XC, Zhang Z, Pattani K, Bermudez F, Jean-Charles G, et al. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions. Clin Cancer Res. 2013;19(12):3268-75. doi:10.1158/1078-0432. CCR-12-3496 PMID: 23637120; PubMed Central PMCID: PMC3687013.
26. Hayashi M, Guerrero-Preston R, Okamura J, Michailidi C, Kahn Z, Li X, et al. Innovative Rapid Gene Methylation Analysis of Surgical Margin Tissues in Head and Neck Cancer. Ann Surg Oncol. 2014. doi: 10.1245/s10434-014-3661-2 PMID: 24671639.
27. Ovchinnikov DA, Cooper MA, Pandit P, Coman WB, Cooper-White JJ, Keith P, et al. Tumor-suppressor Gene Promoter Hypermethylation in Saliva of Head and Neck Cancer Patients. Translational oncology. 2012;5(5):321-6. PMID: 23066440; PubMed Central PMCID: PMC3468923.
28. Guerrero-Preston R, Michailidi C, Marchionni L, Pickering CR, Frederick MJ, Myers JN, et al. Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer. Epigenetics. 2014;9(7).
29. MacDonald JW, Ghosh D. COPA-cancer outlier profile analysis. Bioinformatics. 2006;22(23):2950-1. Epub 2006/08/10. doi:10.1093/bioinformatics/btl433 PMID: 16895932.
30. Ochs MF, Farrar JE, Considine M, Wei Y, Meshinchi S, Arceci RJ. Outlier Analysis and Top Scoring Pair for Integrated Data Analysis and Biomarker Discovery. IEEE/ACM transactions on computational biology and bioinformatics/IEEE, ACM. 2013. doi: DBACF900-6B21-49D2-9D30-F333A1E9CED0. PubMed Central PMCID: PMC4156935.
31. Fertig EJ, Markovic A, Danilova LV, Gaykalova DA, Cope L, Chung CH, et al. Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis. PLoS One. 2013;8(11):e78127. doi:10.1371/journal.pone.0078127 PMID: 24223768; PubMed Central PMCID: PMC3817178.
32. Li R, Ochs MF, Ahn SM, Hennessey P, Tan M, Soudry E, et al. Expression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma. PLoS One. 2014;9(3):e91263. doi:10.1371/journal.pone.0091263 PMID: 24675808; PubMed Central PMCID: PMC3967989.
33. Sun W, Gaykalova DA, Ochs MF, Mambo E, Arnaoutakis D, Liu Y, et al. Activation of the NOTCH pathway in head and neck cancer. Cancer Res. 2014;74(4):1091-104. doi:10.1158/0008-5472. CAN-13-1259 PMID: 24351288; PubMed Central PMCID: PMC3944644.
34. Rathi KS, Gaykalova DA, Hennessey P, Califano JA, Ochs MF. Correcting Transcription Factor Gene Sets for Copy Number and Promoter Methylation Variations. Drug development research. 2014; In Press.
35. Shao C, Tan M, Bishop JA, Liu J, Bai W, Gaykalova DA, et al. Suprabasin is hypomethylated and associated with metastasis in salivary adenoid cystic carcinoma. PLoS One. 2012;7(11):e48582. Epub 2012/11/13. doi:10.1371/journal.pone.0048582 PMID: 23144906; PubMed Central PMCID: PMC3492451.
36. Gaykalova D, Vatapalli R, Glazer CA, Bhan S, Shao C, Sidransky D, et al. Dose-dependent activation of putative oncogene SBSN by BORIS. PLoS One. 2012;7(7):e40389. Epub 2012/07/14. doi:10.1371/journal.pone.0040389 PMID: 22792300; PubMed Central PMCID: PMC3390376.
37. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002;18(11):1427-31. PMID: 12424112.
38. Shao C, Bai W, Junn JC, Uemura M, Hennessey PT, Zaboli D, et al. Evaluation of MYB promoter methylation in salivary adenoid cystic carcinoma. Oral Oncol. 2011;47(4):251-5. doi:10.1016/j. oraloncology.2011.01.008 PMID: 21324728; PubMed Central PMCID: PMC3065551.
39. Kim MS, Yamashita K, Baek JH, Park HL, Carvalho AL, Osada M, et al. N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Cancer Res. 2006;66(7):3409-18. Epub 2006/04/06. doi:10.1158/0008-5472. CAN-05-1608 PMID: 16585162.
40. Bhan S, Negi SS, Shao C, Glazer CA, Chuang A, Gaykalova DA, et al. BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer. Clin Cancer Res. 2011;17(13):4267-76. Epub 2011/05/12. doi:10.1158/1078-0432. CCR-11-0653 PMID: 21558405; PubMed Central PMCID: PMC3172963.
41. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods. 2001;25(4):402-8. doi:10.1006/meth.2001.1262 PMID: 11846609.
42. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80. doi: 10.1186/gb-2004-5-10-r80 PMID: 15461798; PubMed Central PMCID: PMC545600.
43. Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 2010;26(19):2363-7. doi:10.1093/bioinformatics/btq431 PMID: 20688976; PubMed Central PMCID: PMC2944196.
44. Ghosh D. Genomic outlier detection in high-throughput data analysis. Methods Mol Biol. 2013;972:141-53. doi:10.1007/978-1-60327-337-4-9 PMID: 23385536.
45. Ghosh D. Discrete nonparametric algorithms for outlier detection with genomic data. J Biopharm Stat. 2010;20(2):193-208. Epub 2010/03/24. doi:10.1080/10543400903572704 PMID: 20309754; PubMed Central PMCID: PMC2845329.
46. Pepe M. The Statistical Evaluation of Medical Tests for Classification and Prediction. Oxford: Oxford University Press; 2003.
47. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333(6046):1154-7. Epub 2011/07/30. doi:10.1126/science.1206923 PMID: 21798897; PubMed Central PMCID: PMC3162986.
48. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294-301. doi:10.1200/JCO.2011.36.4596 PMID: 21969503; PubMed Central PMCID: PMC3221528.
49. Grimwood J, Gordon LA, Olsen A, Terry A, Schmutz J, Lamerdin J, et al. The DNA sequence and biology of human chromosome 19. Nature. 2004;428(6982):529-35. doi:10.1038/nature02399 PMID: 15057824.
50. Lukic S, Nicolas JC, Levine AJ. The diversity of zinc-finger genes on human chromosome 19 provides an evolutionary mechanism for defense against inherited endogenous retroviruses. Cell death and differentiation. 2014;21(3):381-7. doi:10.1038/cdd.2013.150 PMID: 24162661; PubMed Central PMCID: PMC3921586.